mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.7 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |